Suppr超能文献

世界卫生组织国际卫生条例能力要求对控制 COVID-19 大流行的潜在有效性:对 114 个国家的横断面研究。

The potential effectiveness of the WHO International Health Regulations capacity requirements on control of the COVID-19 pandemic: a cross-sectional study of 114 countries.

机构信息

The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.

Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.

出版信息

J R Soc Med. 2021 Mar;114(3):121-131. doi: 10.1177/0141076821992453. Epub 2021 Feb 9.

Abstract

OBJECTIVES

We examined if the WHO International Health Regulations (IHR) capacities were associated with better COVID-19 pandemic control.

DESIGN

Observational study.

SETTING

Population-based study of 114 countries.

PARTICIPANTS

General population.

MAIN OUTCOME MEASURES

For each country, we extracted: (1) the maximum rate of COVID-19 incidence increase per 100,000 population over any 5-day moving average period since the first 100 confirmed cases; (2) the maximum 14-day cumulative incidence rate since the first case; (3) the incidence and mortality within 30 days since the first case and first COVID-19-related death, respectively. We retrieved the 13 country-specific International Health Regulations capacities and constructed linear regression models to examine whether these capacities were associated with COVID-19 incidence and mortality, controlling for the Human Development Index, Gross Domestic Product, the population density, the Global Health Security index, prior exposure to SARS/MERS and Stringency Index.

RESULTS

Countries with higher International Health Regulations score were significantly more likely to have lower incidence (β coefficient -24, 95% CI -35 to -13) and mortality (β coefficient -1.7, 95% CI -2.5 to -1.0) per 100,000 population within 30 days since the first COVID-19 diagnosis. A similar association was found for the other incidence outcomes. Analysis using different regression models controlling for various confounders showed a similarly significant association.

CONCLUSIONS

The International Health Regulations score was significantly associated with reduction in rate of incidence and mortality of COVID-19. These findings inform design of pandemic control strategies, and validated the International Health Regulations capacities as important metrics for countries that warrant evaluation and improvement of their health security capabilities.

摘要

目的

我们研究了世界卫生组织(WHO)《国际卫生条例》(IHR)能力是否与更好地控制 COVID-19 大流行有关。

设计

观察性研究。

设置

对 114 个国家进行基于人群的研究。

参与者

普通人群。

主要观察指标

对于每个国家,我们提取了以下数据:(1)自首例确诊病例以来的任何 5 天移动平均期间内,每 10 万人 COVID-19 发病率增加的最大值;(2)首例病例以来的 14 天累积发病率最大值;(3)首例病例和首例与 COVID-19 相关死亡病例后 30 天内的发病率和死亡率。我们检索了 13 项国家特定的《国际卫生条例》能力,并构建了线性回归模型,以检验这些能力与 COVID-19 的发病率和死亡率是否相关,同时控制了人类发展指数、国内生产总值、人口密度、全球卫生安全指数、先前 SARS/MERS 暴露情况和严格指数。

结果

《国际卫生条例》评分较高的国家,在首例 COVID-19 诊断后 30 天内,每 10 万人的发病率(β系数-24,95%CI-35 至-13)和死亡率(β系数-1.7,95%CI-2.5 至-1.0)显著较低。其他发病率结果也发现了类似的关联。使用不同回归模型控制各种混杂因素进行分析,结果也显示出相似的显著关联。

结论

《国际卫生条例》评分与 COVID-19 发病率和死亡率的降低显著相关。这些发现为大流行控制策略的设计提供了信息,并验证了《国际卫生条例》能力作为评估和改进卫生安全能力的重要指标,对各国具有重要意义。

相似文献

2
The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
Eur J Epidemiol. 2020 Nov;35(11):1099-1103. doi: 10.1007/s10654-020-00674-9. Epub 2020 Aug 10.
5
International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Cochrane Database Syst Rev. 2021 Mar 25;3(3):CD013717. doi: 10.1002/14651858.CD013717.pub2.
7
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013574. doi: 10.1002/14651858.CD013574.pub2.
8
Systemic resilience to cross-border infectious disease threat events in Europe.
Transbound Emerg Dis. 2019 Sep;66(5):1855-1863. doi: 10.1111/tbed.13211. Epub 2019 May 17.
10

引用本文的文献

1
Learning from COVID-19: A Systematic Review of the IHR-SPAR Framework's Role in the Pandemic Response.
Int J Environ Res Public Health. 2025 Apr 27;22(5):695. doi: 10.3390/ijerph22050695.
4
Analyzing the GHSI puzzle of whether highly developed countries fared worse in COVID-19.
Sci Rep. 2022 Oct 21;12(1):17711. doi: 10.1038/s41598-022-22578-2.
5
Global mapping of epidemic risk assessment toolkits: A scoping review for COVID-19 and future epidemics preparedness implications.
PLoS One. 2022 Sep 23;17(9):e0272037. doi: 10.1371/journal.pone.0272037. eCollection 2022.
7
Prioritizing Global Public Health Investments for COVID-19 Response in Real Time: Results from a Delphi Exercise.
Health Secur. 2022 Mar-Apr;20(2):137-146. doi: 10.1089/hs.2021.0142. Epub 2022 Apr 12.
8
The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future.
Lancet. 2021 Oct 30;398(10311):1619-1662. doi: 10.1016/S0140-6736(21)01787-6. Epub 2021 Oct 20.
9
How to unlock the technology and wisdom of tomorrow?
J R Soc Med. 2021 Mar;114(3):107. doi: 10.1177/01410768211000255.

本文引用的文献

2
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.
Lancet Public Health. 2020 May;5(5):e279-e288. doi: 10.1016/S2468-2667(20)30090-6. Epub 2020 Apr 17.
3
Association between population migration and epidemic control of Coronavirus disease 2019.
Sci China Life Sci. 2020 Jun;63(6):936-939. doi: 10.1007/s11427-020-1695-5. Epub 2020 Apr 14.
5
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.
Lancet Public Health. 2020 May;5(5):e261-e270. doi: 10.1016/S2468-2667(20)30073-6. Epub 2020 Mar 25.
6
COVID-19: what is next for public health?
Lancet. 2020 Feb 22;395(10224):542-545. doi: 10.1016/S0140-6736(20)30374-3. Epub 2020 Feb 13.
7
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures.
Emerg Infect Dis. 2020 May;26(5):976-984. doi: 10.3201/eid2605.190995. Epub 2020 May 17.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验